New drug could help those with congenital adrenal hyperplasia reduce use of corticosteroids: NEJM Dr. Kamal Kant Kohli13 Jun 2024 9:15 AM ISTPeople born with the common form of congenital adrenal hyperplasia lack an enzyme in the adrenal glands needed to make the hormones cortisol and...
Study Reveals Novel Drug in Reducing Corticosteroid Dependence for CAH Patients Anshika Mishra13 Jun 2024 8:15 AM ISTResearchers at the U-M Medical School have found a new medicine, crinecerfont, that might help people with congenital adrenal hyperplasia (CAH) to...
New technique detects novel biomarkers for kidney diseases with nephrotic syndrome: NEJM Dr. Kamal Kant Kohli6 Jun 2024 8:00 AM ISTA groundbreaking study, presented today at the 61st ERA Congress, has uncovered a significant breakthrough in the diagnosis and monitoring of kidney...
Plozasiran: Groundbreaking RNA Interference Agent Targets APOC3 for Mixed Hyperlipidemia suggests research Medha Baranwal5 Jun 2024 10:00 AM ISTUSA: In a groundbreaking development in lipid management, researchers have unveiled a promising RNA interference (RNAi) agent known as Plozasiran....
New study unravels role of interferon gamma in autoimmune polyendocrine syndrome type 1: NEJM Medha Baranwal4 Jun 2024 9:45 AM ISTUSA: Recent research has shed light on the pivotal role of interferon gamma in the pathogenesis of autoimmune polyendocrine syndrome type 1 (APS-1),...
COVID boosters targeting omicron subvariants of SARS-CoV-2 less protective against the now-dominant JN.1 strain: Study Dr. Kamal Kant Kohli31 May 2024 9:00 AM ISTBoosters that target the omicron subvariants of SARS-CoV-2 are still providing reasonably durable protection against infection, hospitalization and...
Very early BP control confers both benefits and harms in acute stroke, suggests study Dr. Kamal Kant Kohli28 May 2024 9:00 AM ISTEarly identification of stroke type could be key to harnessing the benefits of very early in-ambulance blood pressure lowering treatment in patients...
Semaglutide may protect Kidneys in Overweight Patients with Heart Disease, Study finds Anshika Mishra28 May 2024 8:00 AM ISTIn a groundbreaking study published in the New England Journal of Medicine, researchers discovered that semaglutide significantly reduces risk of...
Semaglutide reduces risk of major kidney events and death from CV causes among diabetes patients with CKD: NEJM Dr Kartikeya Kohli27 May 2024 8:15 PM ISTThe FLOW (Evaluate Renal Function with Semaglutide Once Weekly) study is a double-blind, randomised, placebo-controlled international trial comprising...
Dupilumab lowers exacerbations in COPD and type 2 inflammation and improves lung function: NEJM Dr. Kamal Kant Kohli25 May 2024 8:15 AM ISTChronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug-dupilumab-that showed rapid and sustained...
NEJM study reveals Link between COVID-19 vaccine complication and rare 'common cold' blood disease Dr. Kamal Kant Kohli17 May 2024 7:15 AM ISTNew research led by Flinders University and international experts is expanding understanding of vaccine-induced immune thrombocytopenia and thrombosis...
Thrombectomy promising for Stroke with Large Infarct of Unrestricted Size, unravels study Medha Baranwal14 May 2024 7:30 AM ISTFrance: In medical breakthroughs, the recent trial focusing on thrombectomy for stroke with a large infarct of unrestricted size has ignited hope...
